Detection of hemoglobin in blood and urine glucose level samples using a graphene-coated SPR based biosensor

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In this paper, we have presented a design and simulation of a graphene-coated surface plasmon resonance (SPR) based biosensor for targeting specific biological components. We have explicitly shown the detection of the hemoglobin level in blood samples and the glucose concentration level in urine samples by using the finite element method (FEM) based numerical simulation. In the blood component, the 0.001 refractive index increment causes a 6.1025 g/l hemoglobin (HB) level increment, which has been detected using this SPR based sensor with 200 deg/RIU angular sensitivity. Moreover, we have also detected the presence or absence of diabetes using the glucose concentration level in urine samples with this SPR sensor. Therefore, the novelty of this paper is detecting the blood hemoglobin level and glucose concentration levels in urine samples more accurately than the previously proposed whispering gallery mode (WGM) and photonic crystal nanocavity based optical sensors.

Related collections

Most cited references 49

Record: found
Abstract: not found
Article: not found

Graphene and Graphene Oxide: Synthesis, Properties, and Applications

Yanwu Zhu, Shanthi Murali, Weiwei W. Cai … (2010)

There is intense interest in graphene in fields such as physics, chemistry, and materials science, among others. Interest in graphene's exceptional physical properties, chemical tunability, and potential for applications has generated thousands of publications and an accelerating pace of research, making review of such research timely. Here is an overview of the synthesis, properties, and applications of graphene and related materials (primarily, graphite oxide and its colloidal suspensions and materials made from them), from a materials science perspective.

0 comments Cited 1063 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Two-dimensional nanosheets produced by liquid exfoliation of layered materials.

J N Coleman, M. Lotya, A. O'Neill … (2011)

If they could be easily exfoliated, layered materials would become a diverse source of two-dimensional crystals whose properties would be useful in applications ranging from electronics to energy storage. We show that layered compounds such as MoS(2), WS(2), MoSe(2), MoTe(2), TaSe(2), NbSe(2), NiTe(2), BN, and Bi(2)Te(3) can be efficiently dispersed in common solvents and can be deposited as individual flakes or formed into films. Electron microscopy strongly suggests that the material is exfoliated into individual layers. By blending this material with suspensions of other nanomaterials or polymer solutions, we can prepare hybrid dispersions or composites, which can be cast into films. We show that WS(2) and MoS(2) effectively reinforce polymers, whereas WS(2)/carbon nanotube hybrid films have high conductivity, leading to promising thermoelectric properties.

0 comments Cited 734 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

Tilman B. Drueke, Francesco Locatelli, Naomi Clyne … (2006)

Whether correction of anemia in patients with stage 3 or 4 chronic kidney disease improves cardiovascular outcomes is not established. We randomly assigned 603 patients with an estimated glomerular filtration rate (GFR) of 15.0 to 35.0 ml per minute per 1.73 m2 of body-surface area and mild-to-moderate anemia (hemoglobin level, 11.0 to 12.5 g per deciliter) to a target hemoglobin value in the normal range (13.0 to 15.0 g per deciliter, group 1) or the subnormal range (10.5 to 11.5 g per deciliter, group 2). Subcutaneous erythropoietin (epoetin beta) was initiated at randomization (group 1) or only after the hemoglobin level fell below 10.5 g per deciliter (group 2). The primary end point was a composite of eight cardiovascular events; secondary end points included left ventricular mass index, quality-of-life scores, and the progression of chronic kidney disease. During the 3-year study, complete correction of anemia did not affect the likelihood of a first cardiovascular event (58 events in group 1 vs. 47 events in group 2; hazard ratio, 0.78; 95% confidence interval, 0.53 to 1.14; P=0.20). Left ventricular mass index remained stable in both groups. The mean estimated GFR was 24.9 ml per minute in group 1 and 24.2 ml per minute in group 2 at baseline and decreased by 3.6 and 3.1 ml per minute per year, respectively (P=0.40). Dialysis was required in more patients in group 1 than in group 2 (127 vs. 111, P=0.03). General health and physical function improved significantly (P=0.003 and P<0.001, respectively, in group 1, as compared with group 2). There was no significant difference in the combined incidence of adverse events between the two groups, but hypertensive episodes and headaches were more prevalent in group 1. In patients with chronic kidney disease, early complete correction of anemia does not reduce the risk of cardiovascular events. (ClinicalTrials.gov number, NCT00321919 [ClinicalTrials.gov].). Copyright 2006 Massachusetts Medical Society.